Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon

Published:2004-05-25 Issue:23 Volume:101 Page:8705-8708
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Bielekova B.,Richert N.,Howard T.,Blevins G.,Markovic-Plese S.,McCartin J.,Wurfel J.,Ohayon J.,Waldmann T. A.,McFarland H. F.,Martin R.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference16 articles.

1. The use of antibodies against the IL-2 receptor in transplantation

2. Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials1

3. Daclizumab: outcome of phase III trials and mechanism of action

4. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial

5. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Cited by 279 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A genome-wide association study of blood cell morphology identifies cellular proteins implicated in disease aetiology;Nature Communications;2023-08-18

2. Strategies to therapeutically modulate cytokine action;Nature Reviews Drug Discovery;2023-08-04

3. Microbiome and multiple sclerosis;Translational Neuroimmunology, Volume 8;2023

4. NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis;Frontiers in Immunology;2021-12-16

5. In Memoriam—Thomas Alexander Waldmann, M.D.;Journal of Clinical Immunology;2021-11-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3